SAN DIEGO & DORTMUND, Germany--(BUSINESS WIRE)--PROTAGEN AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmune field, and Inova Diagnostics, ...
SAN DIEGO, June 16, 2014 /CNW/ - INOVA Diagnostics Inc., a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the global launch of ...
The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Aptiva addresses many health economic shortcomings in the autoimmune laboratory. Existing systems provide a limited number of analytes that do not reduce the seronegative gap found in many disease ...
Innova Biosciences (Innova) and Mologic have announced the signing of a supply and licensing agreement for use of Innova’s Lightning-Link® and InnovaCoat® GOLD technologies as part of Mologic’s ...
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug ...
SAN DIEGO, Dec. 21, 2017 /PRNewswire/ -- Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce the global launch ...
Inova Diagnostics this week bagged new technology developed at Hasselt University designed to identify a more sensitive collection of biomarkers for rheumatoid arthritis, once again setting its sights ...
SAN DIEGO, Aug. 26, 2020 /PRNewswire/ -- Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce CE (Conformité ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results